Skip to content

Hemodynamic stability during anesthesia induction with ketofol mixture – identifying optimal ratio

Hemodynamic stability during anesthesia induction with propofol/esketamine (ketofol) mixture – identifying optimal ratio

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN59349598
Enrollment
100
Registered
2017-08-02
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective surgery with orotracheal intubation Surgery Elective surgery with orotracheal intubation

Interventions

Participants undergoing elective surgery are randomly allocated to one of three groups. Randomisation is done by an independent person using a draw. The following groups are: Group K1: Participants i

Sponsors

University Clinical Centre Maribor
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years 2. ASA Physical Status I or II 3. Elective surgery with orotracheal intubation

Exclusion criteria

Exclusion criteria: 1. Allergy or sensitivity to any medication used in trial 2. Alcohol or drug abuse 3. Chronical use of benzodiazepins, opiats or psyhothrophic medication 4. Body mass index higher than 35 or lower than 15 5. Anticipated difficult intubation (Mallampati III or IV) 6. Untreated arterial hypertension 7. Patients with Alzheimers, epilepsy or psychosis

Design outcomes

Primary

MeasureTime frame
1. Cardiac output is measured noninvasively using transthoracal electric bioimpedance every minute for first 16 minutes after induction of anesthesia 2. Blood pressure is measured noninvasively using arm cuffs every 2 minutes for first 16 minutes after induction of anesthesia 3. Heart rate is measured by ECG every minute for first 16 minutes after induction of anesthesia

Secondary

MeasureTime frame
1. Bispectral index (BIS) (depth of sedation or anaesthesia) is monitored with 15 seconds sampling using forehead electrodes every minute for first 16 minutes after induction of anesthesia. 2. Dose titrated to clinical effect (loss of palpebral effect)

Countries

Slovenia

Contacts

Public ContactDomen Kogler

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026